$55.64

-0.38 (-0.68%)

8/29/2008 4:04 PM

Novartis AG (ADR) (NVS)

CAPS Rating:

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating NVS

Add Stock to Watchlist

What the Community Thinks

Total Members

861 Outperforms

34 Underperforms

All-Stars

314 Outperforms

5 Underperforms

Wall Street

13 Outperforms

2 Underperforms

Members bullish on NVS are also bullish on:

Members bearish on NVS are also bearish on:

Ticker Tags

Mega Cap (145), Switzerland (11), Top Brands 2005 (65), Bird Flu (8), Big Pharma (12), Dividend (206), Top Brands 2006 (64), Drug Manufacturers - Major (27)
Suggest a tag

Novartis AG (ADR) At A Glance

Current Price:	$55.64
Last Trade Time:	8/29/2008 4:04 PM
Open:	$56.16
Previous Close:	$56.02
Daily Range:	$55.44 - $56.23
52-Week Range:	$46.19 - $61.30
Volume:	834,924
Market Cap:	$148.10B
P/E Ratio:	19.94
Compare Our Special Broker Offers!

Stock Trends

NVS VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for NVS

Novartis plans $235M charge after dropping drug
8/29/2008 12:17:00 PM - AP
NexMed shares plunge on move to nix product filing
8/27/2008 5:14:00 PM - AP
Movers roundup: NexMed, Bristol-Myers Squibb
8/27/2008 2:31:00 PM - AP
Novartis drug receives funding approval
8/27/2008 12:40:00 PM - AP

More Headlines...

Top Bull Pitch

Recs

1 Novartis AG (ADR) (NVS)

Avatar Craiger3 (< 20) Submitted: 7/31/08 2:58 PM

A solid performer. BOT @ $47.50 in my brokerage account and will keep it for many years. Swiss Franc denominated, baby boomers get sick play, and a little dividend = reinvested.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

4 Novartis AG (ADR) (NVS)

Avatar interactdv (< 20) Submitted: 4/06/07 12:45 AM

Zelnorm recall will result in a flurry of class action suits (as palgued Vioxx). While most will be deemed without merit there will be a flood of litigants eager to latch on to some of the extra cash that Novartis has at hand.
Long-term Novartis has an excellent arsenal of drugs and developmen...More

Replies: 0 | Reply | Permalink

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 136 : 1 2 3 4 5 Next » Jump to page:

Recs 0 (NVS) KJByers (68.65) Submitted: 8/21/08 6:25 PM : Start Price: $55.11 NVS Score: 0.83 Morningstar fair value $73 as of 7/21/08 Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (NVS) jawilde (44.82) Submitted: 8/15/08 9:44 AM : Start Price: $56.45 NVS Score: -0.28 Blue chip health care company. Broad diversification compares to Johnson & Johnson versus a purer big pharma play. Nice Total Return potential. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (NVS) COOLSTOCK (22.45) Submitted: 8/06/08 1:55 PM : Start Price: $58.10 NVS Score: -4.57 big pharma buying more company like alcon Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (NVS) nipous (49.22) Submitted: 8/05/08 4:29 PM : Start Price: $57.60 NVS Score: 4.00 After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of months while NVS hangs around somewhat. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 1 (NVS) Craiger3 (< 20) Submitted: 7/31/08 2:58 PM : Start Price: $59.49 NVS Score: -6.99 A solid performer. BOT @ $47.50 in my brokerage account and will keep it for many years. Swiss Franc denominated, baby boomers get sick play, and a little dividend = reinvested. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 136 : 1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 15 of 15

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackCowenandCo	80.53	06/04/08		NS	$52.72	+5.54%	-6.59%	+12.13
	TrackBernstein	84.02	05/09/08		NS	$50.97	+9.16%	-6.94%	+16.11
	TrackHSBC	93.05	02/29/08		NS	$50.11	+11.04%	-5.02%	-16.06
	TrackTobinSmith	< 20	01/25/08		1Y	$48.80	+14.03%	-3.19%	+17.22
	TrackPatDorsey	88.94	11/09/07		5Y	$50.60	+9.96%	-11.26%	+21.22
	TrackEdwardOwens	99.15	09/30/07		NS	$53.38	+4.23%	-15.59%	+19.83
	TrackBrandes	< 20	09/30/07		NS	$53.38	+4.23%	-15.59%	+19.83
	TrackDodgeCox	99.26	09/30/07		NS	$53.38	+4.23%	-15.59%	+19.83
	TrackEveillard	94.67	09/30/07		NS	$53.38	+4.23%	-15.59%	+19.83
	TrackJohnKeeley	96.69	09/30/07		NS	$53.38	+4.23%	-15.59%	+19.83
	TrackUBS	95.67	09/06/07		NS	$51.85	+7.32%	-12.95%	+20.27
	TrackCreditSuiss	96.58	07/18/07		NS	$51.95	+7.10%	-16.49%	-23.59
	TrackJimJubak	91.67	12/01/06		1Y	$55.11	+0.97%	-8.10%	+9.06
	TrackBofASec	96.71	09/11/06		NS	$53.78	+3.45%	-0.82%	+4.28
	TrackJimCramer	81.79	03/29/06		3W	$52.58	+5.82%	-1.22%	+7.03

Results 1 - 15 of 15

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.